Aquestive Therapeutics, Inc. Stock Split Ratio
Aquestive Therapeutics, Inc. (AQST) reported Stock Split Ratio of 1234.00% for the 1-month period ending 2018-07-31, per its 10-K filed 2020-03-11.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-11
- Aquestive Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 100.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|
| 2018-07-31 | 1234.00% 10-K · filed 2020-03-11 | |
| 2018-04-30 | 8.00% 10-Q · filed 2019-11-05 | |
| 2017-12-31 | 100.00% 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |